Precipio, Inc. (NASDAQ:PRPO) Short Interest Down 44.2% in October

Precipio, Inc. (NASDAQ:PRPO) was the recipient of a large drop in short interest during the month of October. As of October 15th, there was short interest totalling 4,800 shares, a drop of 44.2% from the September 30th total of 8,600 shares. Approximately 0.4% of the company’s shares are sold short. Based on an average daily volume of 10,500 shares, the days-to-cover ratio is currently 0.5 days.

Precipio Trading Down 0.5 %

Precipio stock traded down $0.03 during trading on Friday, hitting $6.32. The company had a trading volume of 6,343 shares, compared to its average volume of 7,603. Precipio has a 1-year low of $4.31 and a 1-year high of $8.99. The company’s 50 day simple moving average is $6.52 and its 200-day simple moving average is $5.91. The stock has a market cap of $9.35 million, a price-to-earnings ratio of -2.58 and a beta of 1.41. The company has a current ratio of 0.73, a quick ratio of 0.59 and a debt-to-equity ratio of 0.03.

Precipio (NASDAQ:PRPO) last released its earnings results on Tuesday, August 13th. The biotechnology company reported ($0.83) EPS for the quarter. The company had revenue of $4.44 million for the quarter. Precipio had a negative return on equity of 39.66% and a negative net margin of 22.90%.

About Precipio

Precipio, Inc, a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; and HemeScreen, a suite of robust genetic diagnostic panels.